Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122381) titled 'A Clinical Study of Camrelizumab in Combination with Albumin-Bound Pacli... Read More
Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122413) titled 'Analysis of Efficacy and Safety of Tocilizumab in Elderly Women with Ref... Read More
Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122417) titled 'Therapeutic Factors of Generative AI in Digital Psychological Interventi... Read More
Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122362) titled 'Effects of Instrument-Assisted Constant-Speed Injection versus Manual In... Read More
Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122366) titled 'A head-to-head randomized controlled study comparing spinal cord electri... Read More
Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122397) titled 'Prognosis and influencing factors of ECPR in the treatment of patients w... Read More
Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122374) titled 'Effectiveness and safety of recombinant mussel mucin combined with medic... Read More
Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122389) titled 'A Prospective Observational Study based on Bedside Imaging Monitoring Te... Read More
Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122333) titled 'Viral load and serum cytokine detection as complementary analysis of ear... Read More
Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122336) titled 'Efficacy and Safety of Iparomlimab and Tuvonralimab (QL1706) plus Doceta... Read More